We determined that the putative upstream promoter of the long transcript (P1) of ompA, the gene encoding the major outer membrane protein of Chlamydia trachomatis L2, is recognized in vitro by the major sigma factor of chlamydiae, 66 . We found no evidence that the putative downstream promoter of the short ompA transcript (P1) is functional in vitro. RNase protection of guanylyltransferase-capped transcripts made in vivo confirmed that P2 is a primary transcript while P1 is a processed product of a longer transcript, possibly P2.
, a homolog of the Escherichia coli major sigma factor, 70 (3) . The major 5Ј ends that we identified for transcripts generated in vivo were identical to those identified by Stephens et al. (8) (Fig. 2) . A strong PE signal was observed when in vitro-generated RNA served as the template and LMPE2 was used as the primer (Fig. 2B) ; this signal was identical to the 5Ј end of the long in vivo transcript, suggesting that the P2 promoter region functions in our in vitro system. The same 5Ј end was also identified when LMPE1 was used as the primer (Fig. 2A) . In addition, several bands which roughly correspond to the 5Ј end of the short P1 transcript were noted when RNA generated in vitro was analyzed by PE with primer LMPE1. While these signals may represent termination at 5Ј ends of the P1 transcript, they also may be the result of premature termination of the PE reaction close to the oligonucleotide primer.
To avoid problems inherent in PE analysis, we employed a second method to detect transcripts generated in vitro. The P1 and P2 promoter regions were cloned into the transcription assay vector pUC19-spfЈ, and radiolabelled RNA was generated by using chlamydial RNA polymerase with and without recombinant 66 , [␣-32 P]UTP, and unlabelled nucleoside triphosphates as described previously (3) . Radiolabelled transcripts initiated from the cloned promoters and terminated at the E. coli spf gene terminator were detected directly on DNA sequencing gels. The DNA templates used in the assay are described in Table 1 and schematically represented in Fig. 3 . When pALR210C (which encodes promoter P2 but lacks promoter P1) was used as template and recombinant 66 was included in the reaction mixture, a series of tandem bands was noted on the sequencing gel (Fig. 3 ). This pattern of multiple bands is characteristic of the imprecise termination at the spf terminator and is not the result of initiation of transcription at multiple sites (3) . The length of the transcripts generated from pALR210C was within the range predicted (145 nucleotides) for transcripts initiated from the P2 promoter. No signal above the background level was detected when the reaction was carried out in the absence of added 66 , indicating that the P2 promoter is dependent on the major chlamydial sigma factor.
In addition to the 145 nucleotide transcripts, tandem transcripts of between 115 and 120 nucleotides were noted when pALR210C served as the template. Transcripts in this size range were also generated from the template pALR210D, which lacks both the P1 and P2 promoters (Fig. 3) . In additional experiments (data not shown), we determined that these transcripts were initiated and terminated from chlamydial DNA sequence upstream of the P2 promoter; their function in ompA expression is not known.
If the P1 promoter were active in vitro, a series of transcripts of approximately 115 nucleotides should have been generated from template pALR210X, a plasmid which encodes promoter P1 but not promoter P2. However, multiple transcripts in this size range were not noted (Fig. 3) . A single band of about 113 bases was generated from pALR210X; however, this same band was also noted when the vector pUC19-spfЈ was used as the template. The 113-base transcript, therefore, was initiated and terminated within the vector sequence. When a template designated pALR210A, which encodes both promoters P1 and P2, was examined in the in vitro system, no signal characteristic of P1 was observed (data not shown), suggesting that the failure to detect P1 promoter activity with pALR210X was not due to the absence of distal upstream sequences. In experiments not reported here, we examined C. trachomatis RNA polymerase preparations made from reticulate bodies harvested as early as 12 h p.i. (when the short P1 transcript predominates) for the ability to transcribe from the P1 promoter region, but, as was the case with 20-h preparations, we could detect only P2 promoter activity. All of our observations suggest that P1 is not an ompA promoter that is recognized by 66 in vitro.
Identification of primary ompA transcripts. Our investigations suggest that ompA transcription is initiated in vitro from the P2 but not from the P1 promoter region. To determine whether the P1 and P2 transcripts are generated from their Table 1 ; the thick line indicates spf gene sequences and the stem-loop structure represents the spf terminator. The lengths of transcripts made by functional P1 and P2 promoters are predicted to be 115 nucleotides (template pALR210X) and 145 nucleotides (template pALR210C), respectively, and the expected locations of the transcripts are indicated by the brackets on the right side of the gel. The pUC19-spfЈ vector (lacking the ompA sequence) and pALR202 served as control templates. pALR202 encodes the antisense plasmid transcripts (7) proposed promoters in vivo, we developed an RNase protection assay which distinguishes primary from processed transcripts. We capped the 5Ј ends of RNA isolated from purified C. trachomatis L2 grown in HeLa cells (chlamydial in vivo RNA) with [␣-32 P]GTP, using the eucaryotic capping enzyme guanylyltransferase, as described by Fahr et al. (5) . Guanylyltransferase recognizes the di-and triphosphate groups found at the 5Ј ends of primary transcripts. Processed transcripts which lack these end groups are not recognized; consequently, primary but not processed transcripts are labelled in the guanylyltransferase reaction. As a control, full-length P2 transcripts were generated from a bacteriophage T7 promoter in vitro and then capped with [␣-32 P]GTP. The plasmid pALR4, the template used to generate the in vitro transcripts, was constructed so that T7 RNA polymerase would initiate transcription from the T7 promoter at the P2 start site (it was necessary to replace the A at ϩ1 with a G). The positions of the 5Ј cap sites, assuming that the P1 and P2 transcripts are primary, on the in vitro and in vivo transcripts are shown in Fig. 4A .
The cap-labelled RNAs were hybridized to three different unlabelled complementary (antisense) RNA fragments, designated T3A, T3B, and T3C, that were generated in vitro with bacteriophage T3 RNA polymerase and the templates shown in Fig. 4B . Assuming that both P1 and P2 are primary in vivo transcripts, the unlabelled antisense RNAs are predicted to protect the following 5Ј-capped RNA fragments from RNase: T3A, a 127-nucleotide P1 transcript fragment; T3B, a 348-nucleotide P2 fragment and a 127-nucleotide P1 fragment; and T3C, a 116-nucleotide P2 fragment (Fig. 4B) .
Following treatment of the hybrids with RNase A and RNase T1, the protected chlamydial RNA fragments made in vivo were fractionated by electrophoresis on a DNA sequencing gel (Fig. 5) . Antisense T3A RNA failed to protect a 5Ј-capped fragment of any discrete size (Fig. 5, lane 3) , indicating that the P1 transcript was not capped and, therefore, is not a primary transcript. In contrast, antisense T3C RNA protected RNase digestion and recovery of protected products were carried out according to kit instructions, except that 35 U of RNase T1 and 2 U of RNase A were used for digestion. The protected end-labelled fragments were fractionated on a 6% DNA sequencing gel and detected by autoradiography of the gel. Lanes: 1, capped in vivo RNA (5 g) not treated with RNases; 2, capped in vivo RNA (5 g) treated with RNases; 3, capped in vivo RNA-T3A hybrid treated with RNases; 4, capped in vivo RNA-T3B hybrid treated with RNases; 5, capped in vitro T7 RNA-T3B hybrid treated with RNases; 6, capped in vivo RNA-T3C hybrid treated with RNases; 7, capped T7 in vitro RNA-T3C hybrid treated with RNases. A DNA sequencing ladder is shown at the right; bp 127 is indicated by a dot. Arrows indicate the full-length protection products. Lane 1 was exposed to film for 3 h; the other lanes were exposed for 4 days.
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on July 9, 2017 by guest a capped RNA fragment which was made in vivo (Fig. 5 , lane 6) and identical in length to the 116-nucleotide capped P2 fragment generated in vitro from the T7 promoter (lane 7), indicating that the P2 transcript made in vivo is a primary product of transcription. Antisense T3B RNA protected a capped RNA fragment made in vivo of approximately 348 nucleotides, the size predicted (Fig. 5, lane 4) . This fragment was identical in length to the capped P2 protected fragment made by T7 polymerase in vitro (Fig. 5, lane 5) , further supporting the conclusion that transcription of ompA in infected HeLa cells is initiated at the proposed P2 start site. In addition to the predicted full-length signals in lanes 4 and 6 of Discussion. Our results support the conclusion that the 5Ј end of the P2 transcript is a transcription start site of ompA and that the P2 promoter is dependent for activity on 66 , believed to be the major chlamydial sigma factor. In contrast, our observations indicate that P1 is not a promoter recognized by 66 : we could not detect P1 transcripts in vitro, although we were able to detect P2 transcripts, and we could not cap the P1 transcripts made by C. trachomatis grown in HeLa cells, although we could cap in vivo P2 transcripts. The failure of 66 to recognize the P1 promoter is consistent with the poor homology of P1 with the consensus promoter recognized by other bacterial major sigma factors (Fig. 1) . It is possible that P1 is recognized in vivo by an alternative sigma factor. However, if P1 is a primary transcript and its 5Ј end is stable, it should have been capped by guanylyltransferase and detected in the RNase protection experiment whose results are shown in Fig. 5 . The simplest explanation for our data, therefore, is that the short P1 transcript made by C. trachomatis in vivo is generated from a longer primary transcript, possibly P2.
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